A SGLT2 Inhibitor Dapagliflozin Alleviates Diabetic Cardiomyopathy by Suppressing High Glucose-Induced Oxidative Stress in vivo and in vitroYujie Xing, Xiang Kong, Xin-ming Yao et al.|Frontiers in Pharmacology|2021Cited by 72